Latest News

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

DETROIT (November 19, 2024) – MMS, a leading data and regulatory focused clinical research organization (CRO), today announced its recognition as a Top Workplace by the Detroit Free Press and the USA Today Network for the fourth consecutive year. This prestigious award is based entirely on employee feedback, highlighting the company’s unwavering commitment to fostering a positive and engaging work environment.

The Top Workplaces program surveyed more than 2 million employees from more than 8,000 organizations nationwide in the past year. Consistent inclusion in this list helps illustrate the dedication that MMS has to employee satisfaction and organizational excellence.

“Our colleagues are the foundation of everything we do and our success, and I am deeply grateful for the contributions of our global teams in making MMS a truly special place to work,” said Dr. Uma Sharma, CEO, MMS. “We have created an incredible ecosystem within MMS where science comes first, innovation thrives, and every voice is heard.”

Leading with SOUL: A Sense of Urgency and Leadership

One of the defining features in the continued success of MMS is its corporate value of SOUL, which stands for Sense of Urgency and Leadership. The SOUL mindset is deeply embedded in the company’s culture and has been since its founding in 2006. This ensures that employees at every level are empowered to be a leader, regardless of their role or tenure.

The SOUL philosophy drives MMS employees to complete project work on time, identify risks proactively, and provide innovative solutions, with or without being asked. This entrepreneurial spirit ensures that every colleague takes ownership of their work and its impact on clients, as well as the broader mission of bringing life-changing new therapies to market.

Chris Schoonmaker, COO at MMS, added, “Our SOUL mindset is a key differentiator between MMS and other leading CROs in the pharmaceutical industry. Our nearly 1,000 global colleagues can see their contributions in drug development and achieve their personal aspirations at the same time. Employee engagement is, and will continue to be, one of our top priorities.”

MMS was honored alongside a long list of prominent organizations such as Plante Moran, Progressive Insurance, and Ally Financial. Learn more about MMS at https://mmsholdings.com/solutions/.

About MMS

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating.

For more information, visit www.mmsholdings.com

Media Contact

Don F. McLean
dmclean1@mmsholdings.com

Suggested For You

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

news

April 4th, 2024

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

news

March 6th, 2024

MMS Holdings Inc – A Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale

news

December 13th, 2023

MMS Supported Lykos Therapeutics: NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

news

April 18th, 2023

MMS Named Great Place to Work in the UK as Growth in the Region Doubles

news

March 21st, 2023

MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise

news

February 21st, 2023

MMS Partners with I-ACT to Advance Children’s Clinical Trials

news

February 7th, 2023

Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

news

January 11th, 2023

MMS Named a Great Place to Work in India

news

November 21st, 2022

MMS Named Michigan Top Workplace For The Second Consecutive Year